PON1 and neurodegenerative disease: The occurrence of PON1 in plasma and cerebrospinal fluid (CSF), as well as its antioxidant function, focused the interests of researchers on verifying a potential link between PON1 polymorphisms and the risk of developing neurodegenerative diseases [94].